Exploring The Role Of UKV PLC In Advancing The Wine Business

Every business has its share of challenges and the wine business seems to have unique concerns that affect particularly the quality of the products that are sent to the market. How wine is handled matters and determines the quality of the product after a period of time.

Therefore, it is vital to have developed channels of managing the product and ensuring it is delivered to the right consumers within the right period of time. UKV PLC has invested highly in the development of reliable distribution and marketing channels that ensure wine is delivered in the best manner to the consumer.

Managing warehousing
Although a producer may be in the capacity of offering a superior product to the market, there is no guarantee the company can have the knowledge and expertise to handle warehousing. In fact, many wine producers work with distributors like UKV PLC to ensure the product is preserved well and distributed to the right users. UKV PLC runs highly equipped facilities that ensure wine is kept in pristine quality since the time it is loaded to the facility. UKV PLC manages storage for several producers and has been among the best in wine selection and testing.

Using brokers to handle distribution
Brokers are a unique link between producers, distributors and consumers. They have all the information that these other groups need to make the right decisions and within the right time. UKV PLC understands the value of introducing brokers in the distribution process and the company has been working with some of the best brokers to make the distribution process fast. Through brokers, UKV PLC learns about the preferences and tastes of the users in the market and is able to take action to distribute to targeted users of wine, which allows fast distribution and successful marketing campaigns.

Follow UKV PLC on Instagram

Restraining Order Against Laidlaw

Laidlaw and Company in addition to its principals, Matthew Eitner and James Ahern were issued a temporary restraining order to prevent the dissemination of false and misleading proxy materials regarding the interests of Remalda Therapeutics, Inc. This order was to expire on December 22, 2015. In an effort to protect the Laidlaw stockholders’ interests, the U.S. Federal Court in the District of Nevada issued the order, stalling its takeover attempts.

Laidlaw is an English investment brokerage firm with a history of violations against U.S. financial regulations. As such there have been numerous customer complaints, monetary penalties and regulatory sanctions lodged against them over the years. Because Laidlaw once served as the brokerage firm for Remalda, it gained access to information it is now distorting in an effort to sabotage Remalda Therapeutics.

Remalda is a publicly traded clinical-stage company that develops therapies for the treatment of chronic pain. Their product portfolio includes the drug BuTab and Remalda would prefer to focus on its line of drugs rather than fighting over the control of the company. That is the main reason, they’ve asked the courts to restrict Laidlaw’s take over efforts.

That plus fearing the dissemination of false information could only hurt the shareholder’s interests. Laidlaw and its principals have been ordered to retract false and misleading information. The courts also demanded that the untrue proxy materials stop being issued. Each move is an attempt to restore Remalda to its original condition in the public eye.

Remalda currently has four lead drugs: d-Methadone, topical mepivacaine, oral buprenorphine and LevoCap ER. The company’s development of these drugs is guided by internationally recognized scientific expertise of its research and development team. As of December, 2015 it will also present its stockholders meeting. This shortly after the restraining order expires, giving Laidlaw little opportunity to disrupt the company further.